chlorpromazine has been researched along with diazoxide in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (52.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aynsley-Green, A; Illig, R | 1 |
| Casara, D; Erle, G; Federspil, G; Scandellari, C; Sicolo, N; Zaccaria, M | 1 |
| De Palo, C; Erle, G; Federspil, G; Scandellari, C; Sicolo, N; Zaccaria, M; Zago, E | 1 |
| Vague, PH; Vialettes, B | 1 |
| Herbsman, H; Powers, JC; Shaftan, GW | 1 |
| De Weille, JR; Lazdunski, M; Müller, M | 1 |
| Hellman, B; Sehlin, J; Täljedal, IB | 1 |
| Casara, D; Federspil, G; Stauffacher, W | 1 |
| Bianchetti, A; Jori, A | 1 |
| Hilden, T; Krogsgaard, A; McNair, A; Nielsen, PE | 1 |
| Halawa, B | 1 |
2 review(s) available for chlorpromazine and diazoxide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Treatment of arterial hypertension in elderly patients].
Topics: Age Factors; Aged; Antihypertensive Agents; Chlorpromazine; Diazoxide; Dihydralazine; Drug Therapy, Combination; Furosemide; Humans; Hydrochlorothiazide; Hypertension; Methyldopa; Middle Aged; Spironolactone | 1981 |
3 trial(s) available for chlorpromazine and diazoxide
| Article | Year |
|---|---|
Cerebral symptoms and blood pressure during parenteral administration of chlorpromazine, dihydralazine and diazoxide. Danish multicenter study on acute severe hypertension.
Topics: Blood Pressure; Brain Diseases; Brain Ischemia; Chlorpromazine; Clinical Trials as Topic; Diazoxide; Dihydralazine; Emergencies; Furosemide; Humans; Hydralazine; Hypertension; Hypotension; Paralysis; Risk | 1983 |
[Treatment of acute, severe hypertension assessed in a multicentre study. The effects of rest and furosemide and a randomized clinical trial of chlorpromazine, dihydralazine and diazoxide].
Topics: Adult; Aged; Bed Rest; Chlorpromazine; Clinical Trials as Topic; Diazoxide; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1981 |
Emergency treatment of severe hypertension evaluated in a randomized study. Effect of rest and furosemide and a randomized evaluation of chlorpromazine, dihydralazine and diazoxide. Danish Multicenter Study.
Topics: Adult; Aged; Chlorpromazine; Denmark; Diazoxide; Dihydralazine; Drug Administration Schedule; Female; Furosemide; Humans; Hydralazine; Hypertension; Male; Middle Aged; Posture; Prospective Studies; Random Allocation | 1980 |
20 other study(ies) available for chlorpromazine and diazoxide
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Letter: Enhancement by chlorpromazine of hyperglycaemic action of diazoxide.
Topics: Blood Glucose; Chlorpromazine; Diazoxide; Drug Synergism; Humans; Infant; Male | 1975 |
Medical treatment of endogenous organic hyperinsulinism.
Topics: Adenoma, Islet Cell; Adult; Blood Glucose; Child; Chlorpromazine; Diazoxide; Female; Humans; Hyperinsulinism; Male; Pancreatic Diseases; Phenytoin; Propranolol; Streptozocin | 1976 |
[Medical treatment of spontaneous hypoglycemic syndromes].
Topics: Adenoma, Islet Cell; Chlorpromazine; Diazoxide; Fasting; Glucagon; Glucose; Humans; Hypoglycemia; Liver; Pancreatic Neoplasms; Streptozocin | 1979 |
[Potentiation of the effects of diazoxide by chlorpromazine in the treatment of organic hyperinsulinism].
Topics: Chlorpromazine; Diazoxide; Drug Synergism; Female; Humans; Hyperinsulinism; Middle Aged | 1977 |
Evaluation of various hypotensive agents in the control of experimental hemorrhage.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Chlorpromazine; Diazoxide; Dogs; Drug Evaluation, Preclinical; Guanethidine; Hemorrhage; Hydralazine; Phenoxybenzamine; Protoveratrines; Tolazoline | 1975 |
Chlorpromazine and related phenothiazines inhibit the ATP-sensitive K+ channel.
Topics: Adenosine Triphosphate; Antipsychotic Agents; Chlorpromazine; Diazoxide; Electrophysiology; Insulinoma; Pancreatic Neoplasms; Potassium Channels; Rubidium Radioisotopes; Tumor Cells, Cultured | 1991 |
The pancreatic -cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylureas.
Topics: Animals; Antimycin A; Carbon Isotopes; Chlorpromazine; Diazoxide; Glucose; Glyburide; In Vitro Techniques; Islets of Langerhans; Leucine; Male; Mice; Serum Albumin; Sulfur Isotopes; Tolbutamide | 1973 |
Chlorpromazine in the treatment of endogenous organic hyperinsulinism.
Topics: Adult; Bendroflumethiazide; Blood Glucose; Chlorpromazine; Diazoxide; Female; Glucose Tolerance Test; Hirsutism; Humans; Hyperinsulinism; Hypoglycemia; Insulin Antagonists; Nausea; Pancreas | 1974 |
Effect of benzyloxyguanidine (13958 RP) on the increase of blood glucose and plasma free fatty acids induced by various drugs in rats.
Topics: Animals; Blood Glucose; Body Temperature; Chlorpromazine; Diabetes Mellitus, Experimental; Diazoxide; Epinephrine; Fatty Acids, Nonesterified; Female; Guanidines; Norepinephrine; Rats; Reserpine | 1967 |